Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UTP Inhalation for Lung Cancer Diagnosis
NCT00210080Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Apr 2001
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in lung cancer comparing UTP Solution with Placebo (2 arms). Primary endpoint: Proportion of lung cancers (malignancies) diagnosed by sputum cytology. Started Apr 2001; status: completed.
02
Drugs
uridine triphosphate
03
Conditions
lung cancer
Beyond the preview
Go deeper on NCT00210080.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00210080.